Consensus Core Laboratories Inc.

Stocks

CLB

US21867A1051

Business Support Services

Real-time Estimate Cboe BZX 18:10:00 15/10/2026 BST			5-day change	1st Jan Change
9.605 ^USD	-1.69%		-5.71%	-40.24%

08-25	Core Laboratories Inc. Announces Resignation of Kwaku Temeng as Director, Chairman of the Nominating Committee and as A Member of the Compensation Committee, Effective October 1, 2026	CI
07-30	Core Laboratories Inc., Q2 2026 Earnings Call, Jul 30, 2026

Evolution of the Average Target: Core Laboratories Inc.

Evolution of the Target Price: Core Laboratories Inc.

Changes in Analyst Recommendations: Core Laboratories Inc.

2ccf41.hSe6UvK7av8F-y-UM4fk65bdvE9kfJxcQaL74rs7cSs._WL0HqDdWMY2kkulHteMpfuNzCEhJfUoM--NvdlJJV_Sdd8dtotcu1qLdg~228cc64dd91c568b0127575782026569

Analysts' recommendations: Core Laboratories Inc.

07-15	BofA Securities Adjusts Core Laboratories Price Target to $11 From $12	MT
12/03/25	Citigroup Upgrades Core Laboratories to Neutral From Sell, Adjusts Price Target to $16 From $15	MT
06/03/25	Zephirin Adjusts Price Target on Core Laboratories to $18 From $22, Maintains Buy Rating	MT
25/10/24	The Zephirin Group Upgrades Core Laboratories to Buy from Hold; Adjusts Price Target to $22 from $18	MT
25/10/24	Zephirin Group Upgrades Core Laboratories to Buy Medium Risk From Hold Medium Risk, Raises Price Target to $22 From $18	MT
15/07/24	Piper Sandler Adjusts Core Laboratories Price Target to $17 From $18, Maintains Neutral Rating	MT
29/01/24	Stifel Adjusts Price Target on Core Laboratories to $21 From $23, Maintains Hold Rating	MT
18/09/23	Citigroup Trims Price Target on Core Laboratories to $20 From $21, Maintains Sell Rating	MT
31/07/23	Piper Sandler Adjusts Core Laboratories' Price Target to $21 From $18, Keeps Neutral Rating	MT
30/06/23	Citigroup Downgrades Core Laboratories to Sell From Neutral, Trims Price Target to $21 From $22	MT
01/05/23	Morningstar Upgrades Core Laboratories to Buy From Hold, $29 Price Target	MT
01/05/23	Piper Sandler Adjusts Core Laboratories' Price Target to $19 From $18, Keeps Neutral Rating	MT
28/04/23	Stifel Adjusts Core Laboratories' Price Target to $25 From $24, Keeps Hold Rating	MT
18/04/23	BofA Downgrades Core Laboratories to Underperform From Neutral, Price Target is $21.50	MT
07/02/23	Citigroup Adjusts Price Target on Core Laboratories N.V to $26 From $21, Maintains Neutral Rating	MT
09/01/23	BofA Securities Upgrades Core Laboratories to Neutral From Underperform	MT
07/10/22	Citigroup Upgrades Core Laboratories to Neutral From Sell, Adjusts Price Target to $17 From $24	MT
26/09/22	Morgan Stanley Downgrades Core Laboratories to Underweight From Equal Weight, Keeps $20 Price Target	MT
02/08/22	Cowen Lowers Core Laboratories Price Target to $17 From $22, Maintains Market Perform Rating	MT
01/08/22	Morgan Stanley Lowers Core Laboratories' Price Target to $20 From $22, Maintains Equalweight Rating	MT
15/07/22	BofA Securities Adjusts Core Laboratories Price Target to $17 From $25, Maintains Underperform Rating	MT
13/07/22	Morgan Stanley Adjusts Core Laboratories' Price Target to $22 from $32, Keeps Equalweight Rating	MT
13/07/22	Morgan Stanley Adjusts Core Laboratories N.V 's Price Target to $22 From $32, Keeps Equalweight Rating	MT
02/05/22	Morgan Stanley Adjusts Core Laboratories' Price Target to $32 from $35, Keeps Equalweight Rating	MT
18/04/22	Piper Sandler Downgrades Core Laboratories to Underweight From Neutral	MT

More recommendations

Testing Laboratories

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	CORE LABORATORIES INC.					+53.53%
	VISA, INC.					+7.42%
	CINTAS CORPORATION					+4.64%
	UNITED RENTALS, INC.					+21.87%
	NEBIUS GROUP					+52.46%
	PAYPAL HOLDINGS, INC.					+1.35%
	BLOCK, INC.					+29.4%
	SUNBELT RENTALS HOLDINGS, INC.					+17.14%
	CORPAY, INC.					+17.3%
	FISERV, INC.					+28.33%
	Average					+23.34%
	Weighted average by Cap.					+11.82%